Bromodomain-containing protein 9 (BRD9), a specific component of the non-canonical mammalian SWI/SNF chromatin remodelling complex, is essential to maintain the transformed phenotype of acute myeloid leukemia and the growth of synovial sarcoma [161,193]. This evidence concerns the gene BRD9 and synovial sarcoma.